A Medicare Part D plan can look inexpensive on a marketing flyer and still cost a enrollee far more than expected over the course of a year. The reason is that drug coverage is not priced by a single number. It is built from three interlocking pieces: a monthly premium, a deductible that must be satisfied before some coverage begins, and a formulary — the plan’s own list of covered drugs, organized into cost-sharing tiers and often wrapped in rules about who may fill which prescription and when.
Each piece is set or constrained by federal rules, but each is also a business decision made by the insurer offering the plan. That combination of regulation and plan discretion is why two plans in the same county can advertise similar premiums yet produce very different out-of-pocket totals for the same person. The sections below explain how each component works, what official data sources publish about it, and how to read that data without drawing the wrong conclusions.
Premiums: The Monthly Price Tag and What Sits Behind It
The premium is the amount an enrollee pays each month to remain in a Part D plan, separate from the Part B premium that most Medicare beneficiaries already pay. It is the most visible cost and the one most often used to compare plans, which is precisely why it can be misleading. A premium reflects a plan’s bid to the Centers for Medicare & Medicaid Services (CMS), its expected drug costs, federal subsidies and risk-sharing arrangements, and the plan’s own competitive strategy. Because those inputs differ by region, premiums vary by state and even by county, not just by insurer.
Two structural points matter for interpretation. First, standalone prescription drug plans (PDPs) and Medicare Advantage plans that include drug coverage (MA-PD) are priced differently, so a premium comparison across those two categories is not apples to apples. Second, higher-income enrollees may owe an income-related monthly adjustment amount on top of the plan premium, which means the advertised figure does not apply uniformly to everyone. A late enrollment penalty can also be added permanently if someone goes without creditable drug coverage for too long after becoming eligible.
The single biggest mistake consumers make is treating the lowest premium as the cheapest plan. A plan with a modest premium may apply a deductible to more tiers, place a frequently used drug on a higher tier, or require prior authorization that delays a prescription. Because plan offerings change every year — plans enter, exit, and restructure their benefits — a plan that fit well in one year may not be the same product the next. CMS publishes plan-level data and maintains the Medicare Plan Finder as the authoritative comparison tool, and independent reference sites also compile state-level counts so readers can see how many options exist in a given market before drilling into details; aggregate listings such as medicare part d plans 2027 by state are useful for that first orientation step, but the official plan documents and Plan Finder remain the source for actual premiums and coverage rules.
When reading premium statistics, note what is being averaged. A national average premium does not describe any single market, and a state average can mask wide county-level variation. Enrollees should treat any published average as context, not as a quote.
Deductibles and Cost-Sharing: When Coverage Actually Begins
A deductible is the amount an enrollee pays out of pocket for covered drugs before the plan begins contributing its share. CMS sets a maximum standard deductible each year, and plans may adopt that maximum, choose a lower amount, or — for certain plan types — apply no deductible at all. Crucially, not every drug counts toward the deductible in the same way, and some plans waive the deductible for lower tiers while applying it to higher ones. That nuance is frequently lost in summary descriptions.
After the deductible comes cost-sharing, which typically takes one of two forms: a flat copayment (a set amount per fill) or coinsurance (a percentage of the drug’s negotiated price). Which one applies depends on the drug’s tier on the plan’s formulary. Generic drugs usually sit on lower tiers with modest cost-sharing; brand drugs and specialty medications sit higher. Because coinsurance is a percentage, the dollar amount can vary with the price of the drug, so two plans with identical percentage coinsurance can produce different totals if their negotiated prices differ.
Part D also includes a catastrophic phase in which cost-sharing drops sharply once an enrollee’s out-of-pocket spending reaches a threshold, and federal law now caps annual out-of-pocket spending on covered Part D drugs, with the cap adjusted over time. Enrollees should confirm the current figure through CMS rather than relying on older articles. People with limited income and resources may qualify for the Low-Income Subsidy, known as Extra Help, which can reduce or eliminate premiums and deductibles and lower cost-sharing — a program worth checking before assuming a plan is unaffordable.
Consider a realistic scenario without attaching invented figures: an enrollee takes one generic and one brand medication. Plan A has a low premium and a deductible that applies to the brand tier. Plan B has a higher premium but no deductible and places the brand drug on a preferred tier. Depending on fill frequency and pharmacy, Plan B may cost less annually despite the higher monthly bill. That is the calculation the Plan Finder is designed to perform, and it is why a side-by-side total-cost estimate beats a premium-only comparison.
Formularies: The Drug List That Decides What Is Covered
The formulary is a plan’s list of covered prescription drugs, organized into tiers that determine cost-sharing. Formularies are not static documents; they are negotiated annually between plans and manufacturers, and the placement of a drug on a tier directly affects what an enrollee pays. A drug absent from the formulary is generally not covered at all, except through an exceptions process.
Formularies also carry utilization management tools. Prior authorization requires the prescriber to obtain plan approval before certain drugs are covered. Step therapy requires trying a lower-cost alternative first. Quantity limits cap how much of a drug a plan will cover in a given period. These rules are legitimate cost-control mechanisms, but they create practical friction: a prescription that is technically covered may still require paperwork, a physician’s involvement, or a switch to a different medication. Plan members should read the formulary entry for every drug they take, not just confirm that the name appears.
Federal rules provide safeguards. Plans must have a formal exceptions process, must generally continue coverage at some level for drugs affected by mid-year formulary changes, and must provide transition supplies for new enrollees who are already taking a medication. Network rules matter too: cost-sharing can differ between standard and preferred pharmacies, so the formulary and the pharmacy network should be evaluated together.
For readers working from public data, it helps to distinguish between plan counts and plan substance. Knowing how many plans are offered in a state says nothing about whether any of them cover a specific drug at a specific tier. CMS publishes formulary and pharmacy network files that support detailed comparison, and the Plan Finder allows enrollees to enter their medications and see estimated annual costs. The most reliable method is to verify each drug against each plan’s own formulary document, confirm tier and restrictions, check the pharmacy, and re-verify during the annual open enrollment period — because the numbers on the label and the numbers at the counter are only the same when all three components are examined together.
A Sofia-born astrophysicist residing in Buenos Aires, Valentina blogs under the motto “Science is salsa—mix it well.” Expect lucid breakdowns of quantum entanglement, reviews of indie RPGs, and tango etiquette guides. She juggles fire at weekend festivals (safely), proving gravity is optional for good storytelling.
